Page last updated: 2024-10-30

losartan and Sarcoidosis

losartan has been researched along with Sarcoidosis in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Research Excerpts

ExcerptRelevanceReference
" This case report presents the successful treatment of severe heart failure with prednisone, glycosides and an angiotensin-1 receptor antagonist."3.70[Heart failure as a cardiac symptom of sarcoidosis. Successful treatment of heart failure with steroids, digitalis and an angiotensin-1-receptor antagonist in sarcoidosis]. ( Erbel, R; Kuntz, S; Oldenburg, O; Philipp, T; Sack, S; Schäfers, RF; Weber, F, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamorro-Pareja, N1
Marin-Acevedo, JA1
Chirilă, RM1
Oldenburg, O1
Schäfers, RF1
Kuntz, S1
Sack, S1
Erbel, R1
Philipp, T1
Weber, F1

Reviews

1 review available for losartan and Sarcoidosis

ArticleYear
Cardiac sarcoidosis: Case presentation and Review of the literature.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2019, Mar-01, Volume: 57, Issue:1

    Topics: Cardiomyopathies; Cardiovascular Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressiv

2019

Other Studies

1 other study available for losartan and Sarcoidosis

ArticleYear
[Heart failure as a cardiac symptom of sarcoidosis. Successful treatment of heart failure with steroids, digitalis and an angiotensin-1-receptor antagonist in sarcoidosis].
    Medizinische Klinik (Munich, Germany : 1983), 2000, Mar-15, Volume: 95, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardiomyopathies; Digitoxin; Drug Therapy,

2000